Rigel Pharmaceuticals: Behind The Huge Rally (NASDAQ:RIGL)

Core Insights - Rigel Pharmaceuticals, Inc. (RIGL) has experienced a significant increase in share price over the past month, driven by better-than-expected Q3 results [1]. Company Performance - The Q3 results for Rigel Pharmaceuticals exceeded market expectations, contributing to the recent rally in its stock price [1]. Market Commentary - The Biotech Forum, led by an experienced market analyst, provides insights into high beta sectors and offers a model portfolio of 12-20 biotech stocks with high upside potential [1].